SEI Investments
ARMP icon

SEI Investments’s Armata Pharmaceuticals ARMP Stock Holding History

SEI Investments’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-74,192
Closed -$760K – 3282
2026
Q1 		$760K Buy
+74,192
New +$624K ﹤0.01% 2487

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

SEI Investments's ARMP Position: Q2 2026 in Review

SEI Investments sold out of Armata Pharmaceuticals (ARMP) in Q2 2026, closing a stake of 74,192 shares — an estimated $760K sold.

SEI Investments first reported a position in ARMP in Q1 2026 and held it in 1 quarter. The position peaked at $760K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • SEI Investments reported no remaining Armata Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SEI Investments sold 74,192 Armata Pharmaceuticals shares in Q2 2026, an estimated $760K.
  • SEI Investments first reported a position in Armata Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • SEI Investments's Armata Pharmaceuticals position peaked at $760K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.